Keimpema, L. van

liver patient polycystic polycystic liver disease volume disease lanreotide liver volume treatment kidney month study polycystic liver adpkd 12 months polycystic kidney disease kidney volume radboud university nijmegen change 6 months transplantation liver transplantation symptom trial result university placebo hepatology effect department range keimpema autosomal table mutation hepatic center gastroenterology baseline nijmegen somatostatin diagnosis polycystic livers complication lanreotide treatment survival somatostatin analogues group cohort hospital pcld patients centre netherland drenth transplant therapy analogue signi outcome adpkd patients analysis aliment pharmacol octreotide polycystic kidneys follow-up liver cysts quality level figure increase health difference prkcsh hepatic cysts graft survival ficant graft polycystic liver volume university hospital leuven signi ficant change